We are live on ! Find out more
FM

Frazier Management Portfolio holdings

AUM $1.12M
1-Year Est. Return 151.58%
This Fund
S&P 500
This Quarter Est. Return
+128.37%
1 Year Est. Return
+151.58%
3 Year Est. Return
+408.4%
5 Year Est. Return
+1,802.6%
10 Year Est. Return
–
AUM
$204M
AUM Growth
+$78.4M
Cap. Flow
-$15.1M
Cap. Flow %
-7.38%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
1
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
IOVA icon
Iovance Biotherapeutics
IOVA
+$11.1M

Top Sells

Rank Stock Value
1
GKOS icon
Glaukos
GKOS
+$25.3M
2
FOLD
Amicus Therapeutics
FOLD
+$848K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TBRA
1
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$106M 52.04%
2,668,570
– –
COLL icon
2
Collegium Pharmaceutical
COLL
$820M
$36.4M 17.84%
1,887,332
– –
FOLD
3
DELISTED
Amicus Therapeutics
FOLD
$19.2M 9.44%
2,600,014
-125,577
-5% -$848K
IOVA icon
4
Iovance Biotherapeutics
IOVA
$3.74B
$17.2M 8.43%
2,087,281
+1,312,561
+169% +$11.1M
CDTX
5
DELISTED
Cidara Therapeutics
CDTX
$15M 7.37%
65,613
– –
RXDX
6
DELISTED
Ignyta, Inc.
RXDX
$5.98M 2.93%
950,366
– –
SRRA
7
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$3.98M 1.95%
54,655
– –
GKOS icon
8
Glaukos
GKOS
$10.7B
– –
-867,788
Closed -$25.3M

Similar funds

ACMV
August Capital Management VI Palo Alto, California $1.39M AUM
FRCMI
First Round Capital Management III Philadelphia, Pennsylvania $418K AUM
DB
DCVC Bio Palo Alto, California $313K AUM
NAM
Newfleet Asset Management Hartford, Connecticut $2.05M AUM 27.28% 1-Year Est. Return
AP
Atlas Principals Charlotte, North Carolina $2.19M AUM 56.71% 1-Year Est. Return
ID
Inspire Developers Forest Hills, New York $4.07M AUM
CI
CMT Investments Chicago, Illinois $5M AUM 15.27% 1-Year Est. Return
DIF
Discovery Investment Fund Singapore $6.98M AUM

Frazier Management's Q3 2016 Portfolio in Review

As of Q3 2016, Frazier Management held 8 positions worth $204M, up 63% from $125M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Frazier Management withdrew a net $15.1M in Q3 2016, closing 1 position and reducing 1 holding. Its most notable exit was Glaukos, an estimated $25.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Frazier Management added an estimated $11.1M to Iovance Biotherapeutics.

  • Frazier Management added most to Iovance Biotherapeutics in Q3 2016, an estimated $11.1M increase.
  • Frazier Management's biggest Q3 2016 reduction was Amicus Therapeutics, cutting an estimated $848K.
  • Frazier Management fully exited Glaukos in Q3 2016, selling an estimated $25.3M.
  • Frazier Management's ten largest holdings make up 100% of its $204M portfolio in Q3 2016.
  • Frazier Management opened 0 new positions and closed 1 in Q3 2016.
  • Frazier Management's portfolio value rose 63% quarter-over-quarter to $204M.

Based on Frazier Management's 13F filing for Q3 2016, filed 14 Nov 2016.